Hong Kong: Stocks finish week lower on persistent virus worries
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[SHANGHAI] Hong Kong stocks slipped on Friday to finish the week lower, tracking other Asian markets, spurred by doubts about progress in developing drugs to treat Covid-19 and new evidence of US economic damage caused by the coronavirus pandemic.
The Hang Seng index fell 0.6 per cent, to 23,831.33, while the China Enterprises Index lost 0.5 per cent, to 9,656.19 points.
US business activity plumbed record lows in April, mirroring dire figures from Europe and Asia as strict stay-at-home orders crushed production, supply chains and consumer spending, a survey showed.
Corporate earnings of Hong Kong listed companies were generally worse than expected, which could dampen the room for a valuations recovery in Hong Kong equities, brokerage Cinda International noted in report.
Investors need to pay attention to the implementation China's fiscal and monetary policies, as boosting domestic demand would become a policy focus given the uncertain global economic outlook, the brokerage added.
China's central bank cut the interest rate on its targeted medium-term lending facility on Friday, following similar reductions to borrowing costs on other liquidity tools in the past few weeks to support the economy.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
In the latest bid to bolster domestic consumption, China announced a plan to extend subsidies for buying NEVs to 2022, and tax exemptions on purchases for two years.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium